Last reviewed · How we verify
Mucositis following radiation therapy
Approved treatments
- Kepivance · Biovitrum Ab
Kepivance works by binding to fibroblast growth factor receptor 2, stimulating the growth and proliferation of mucosal cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Mucositis following radiation therapy patent landscape — cliff calendar, originator estates, attackable patents
- Mucositis following radiation therapy treatment landscape brief
- Mucositis following radiation therapy treatment updates RSS
Frequently asked questions about Mucositis following radiation therapy
What drugs treat Mucositis following radiation therapy?
Tracked treatments include Kepivance.
What is the treatment for Mucositis following radiation therapy?
Standard treatment for Mucositis following radiation therapy includes Kepivance. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Mucositis following radiation therapy patent cliff · Mucositis following radiation therapy CI report
- Treatment: Kepivance · Biovitrum Ab
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing